Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Efficacy and Safety of Venetoclax Combined With Decitabine Versus Conventional "7+3" Induction Chemotherapy of Acute Myeloid Leukemia in Young Adults

NCT05177731 is registered in ClinicalTrials.gov with Chen Suning as lead sponsor.

NCT NCT05177731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05177731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Efficacy and Safety of Venetoclax Combined With Decitabine Versus Conventional "7+3" Induction Chemotherapy of Acute Myeloid Leukemia in Young Adults
Lead sponsor
Chen Suning
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 1, 2022
Completion date
December 31, 2024
Enrollment
188 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult, chemotherapy effect